Home  |  Current Issue  |  All Issues  |  Online Submission  |  Subscription  |  Contact Us
Article Search Advanced
  Journal Online
  Ahead of publication
  Current issue
  All issues
  Home on Elsevier
  Manuscript Submission
  Online submission
  Online review
  Instruction for Authors
  Instruction for Reviewers
  Journal Home
  About the journal
  About the chief editor
  Editorial board
  Subscription
  Advertising and reprints
  Acknowledgements to
  reviewers
  Indexed/Abstracted
  Copyright transfer
  Contact us
  Links
PubMed/MEDLINE
Clarivate Analytics
Digestive Surgery
Pancreatology
Freemedicaljournals
BioInfoBank Library
SCImago
Open J-Gate
ResearchGate
Eastliver
  Hepatobiliary Pancreat Dis Int
 
2022 Vol.  21 No.  5
Published: 15 October 2022

Pages 307-408
ORIGINAL ARTICLES/Liver
ORIGINAL ARTICLES/Biliary
LETTERS TO THE EDITOR
GUIDELINES
Special issue on modern technology in liver surgery and transplantation
Special issue on cancer immunotherapy in hepatobiliary malignancies
Special issue on cancer immunotherapy in hepatobiliary malignancies
409 Qin LX
Immunotherapy for hepatobiliary malignancies: Progress and prospective
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 409-412.
[Abstract] HTML (1 KB)  PDF (0 KB)  
413 Lin ZF, Qin LX, Chen JH
Biomarkers for response to immunotherapy in hepatobiliary malignancies Hot!
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 413-419.
[Abstract] HTML (1 KB)  PDF (0 KB)  
420 Zhu Y, Qin LX
Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma Hot!
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 420-429.
[Abstract] HTML (1 KB)  PDF (0 KB)  
430 Xiong J, Wang QQ
Mechanisms and strategies to overcome immunotherapy resistance in hepatobiliary malignancies Hot!
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 430-439.
[Abstract] HTML (1 KB)  PDF (0 KB)  
440 Yuan ZG, Zeng TM, Tao CJ
Current and emerging immunotherapeutic approaches for biliary tract cancers
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 440-449.
[Abstract] HTML (1 KB)  PDF (0 KB)  
450 Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, Zhao LJ, Zhao HT
Novel cellular therapies for hepatobiliary malignancies
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 450-454.
[Abstract] HTML (1 KB)  PDF (0 KB)  
Special issue on modern technology in liver surgery and transplantation
455 Balci D, Kirimker EO, Raptis DA, Gao Y, Kow AWC
Uses of a de dicate d 3D reconstruction software with augmented and mixed reality in planning and performing advanced liver surgery and living donor liver transplantation (with videos)?
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 455-461.
[Abstract] HTML (1 KB)  PDF (0 KB)  
GUIDELINES
462 Xu M, Xie LT, Xiao YY, Liang P, Zhao QY, Wang ZM, Chai WL, Wei YT, Xu LF, Hu XK, Kuang M, Niu LZ, Yao CG, Kong HY, Tian G, Xie XY, Cui XW, Xu D, Zhao J, Jiang TA
Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022)
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 462-471.
[Abstract] HTML (1 KB)  PDF (0 KB)  
ORIGINAL ARTICLES/Liver
472 Xu XB, Hu C, Yang HJ, Zheng SS
Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 472-478.
[Abstract] HTML (1 KB)  PDF (0 KB)  
479 Cheng DY, Zhao ZM, Wan G, Zheng HW, Huang JQ, Liu CH, Xing HC
Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 479-484.
[Abstract] HTML (1 KB)  PDF (0 KB)  
ORIGINAL ARTICLES/Biliary
485 Fu J, McGrath NA, Lee J, Wang X, Brar G, Xie C
Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 485-492.
[Abstract] HTML (1 KB)  PDF (0 KB)  
493 Choi JH, Lee KJ, Paik WH, Park N, Chun JW, Lee SH, Ryu JK, Kim YT
Acetylsalicylic acid for metal stent in malignant distal common bile duct obstruction: A randomized controlled trial
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 493-499.
[Abstract] HTML (1 KB)  PDF (0 KB)  
LETTERS TO THE EDITOR
500 Inoue T, Kitano R, Yoneda M
Troubleshooting of reinterventions after stent-by-stent placement for malignant hilar biliary obstruction (with videos)
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 500-502.
[Abstract] HTML (1 KB)  PDF (0 KB)  
503 Huang JJ, Ma RW, Li DZ, Yin SY, Liu Z, Zhou L, Yan KP, Zheng SS
Ultrasound-guided in vivo porcine liver ablation with nanosecond pulsed electric fields
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 503-507.
[Abstract] HTML (1 KB)  PDF (0 KB)  
508 Jegatheeswaran S, Finch LM, Siriwardena MC, Siriwardena AK
The terminology of the 2012 Atlanta consensus conference on post-inflammatory collections after acute pancreatitis: An assessment of utilization in practice
Hepatobiliary Pancreat Dis Int. 2022; 21(5): 508-510.
[Abstract] HTML (1 KB)  PDF (0 KB)  

ScholarOne Manuscripts Log In

User ID:

Password:

Forgot your password?

Enter your e-mail address to receive an e-mail with your account information.

  Submission Guidance
  Top cited articles
- Most Cited Hepatobiliary & Pancreatic Diseases International Articles
- Most Downloaded Hepatobiliary & Pancreatic Diseases International Articles
more>>  
  Top downloaded articles
more>>  
  Services
Sign up for e-alerts
Web feed
hbpdint@126.com
  hbpdje@zju.edu.cn


Copyright © Official Publication of First Affiliated Hospital
Official Publication of First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
浙ICP备05050873号-1